These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 33120460)

  • 1. [Early onset epileptic encephalopathy caused by mitochondrial arginyl-tRNA synthetase gene deficiency: report of two cases and literature review].
    Jiang HF; Deng J; Fang F; Li H; Wang XH; Dai LF
    Zhonghua Er Ke Za Zhi; 2020 Nov; 58(11):893-899. PubMed ID: 33120460
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical and genetic analysis of infants with pontocerebellar hypoplasia type 6 caused by RARS2 variations.
    Zhao S; Lian R; Jin L; Li M; Jia T; Xu F; Du K; Wang L; Guo Q; Dong Y
    Epilepsia Open; 2024 Feb; 9(1):250-257. PubMed ID: 38009286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel homozygous RARS2 mutation in two siblings without pontocerebellar hypoplasia - further expansion of the phenotypic spectrum.
    Lühl S; Bode H; Schlötzer W; Bartsakoulia M; Horvath R; Abicht A; Stenzel M; Kirschner J; Grünert SC
    Orphanet J Rare Dis; 2016 Oct; 11(1):140. PubMed ID: 27769281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Distinct magnetic resonance imaging features in a patient with novel
    Zhang J; Zhang Z; Zhang Y; Wu Y
    Exp Ther Med; 2018 Jan; 15(1):1099-1104. PubMed ID: 29434700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RARS2 mutations cause early onset epileptic encephalopathy without ponto-cerebellar hypoplasia.
    Nishri D; Goldberg-Stern H; Noyman I; Blumkin L; Kivity S; Saitsu H; Nakashima M; Matsumoto N; Leshinsky-Silver E; Lerman-Sagie T; Lev D
    Eur J Paediatr Neurol; 2016 May; 20(3):412-7. PubMed ID: 26970947
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Early infantile epileptic encephalopathy caused by PACS2 gene variation: three cases report and literature review].
    Wu MJ; Hu CH; Ma JH; Hu JS; Liu ZS; Sun D
    Zhonghua Er Ke Za Zhi; 2021 Jul; 59(7):594-599. PubMed ID: 34405643
    [No Abstract]   [Full Text] [Related]  

  • 7. A patient with pontocerebellar hypoplasia type 6: Novel RARS2 mutations, comparison to previously published patients and clinical distinction from PEHO syndrome.
    Nevanlinna V; Konovalova S; Ceulemans B; Muona M; Laari A; Hilander T; Gorski K; Valanne L; Anttonen AK; Tyynismaa H; Courage C; Lehesjoki AE
    Eur J Med Genet; 2020 Mar; 63(3):103766. PubMed ID: 31536827
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pontocerebellar hypoplasia type 6 caused by mutations in RARS2: definition of the clinical spectrum and molecular findings in five patients.
    Cassandrini D; Cilio MR; Bianchi M; Doimo M; Balestri M; Tessa A; Rizza T; Sartori G; Meschini MC; Nesti C; Tozzi G; Petruzzella V; Piemonte F; Bisceglia L; Bruno C; Dionisi-Vici C; D'Amico A; Fattori F; Carrozzo R; Salviati L; Santorelli FM; Bertini E
    J Inherit Metab Dis; 2013 Jan; 36(1):43-53. PubMed ID: 22569581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subdural effusions and lack of early pontocerebellar hypoplasia in siblings with RARS2 mutations.
    Kastrissianakis K; Anand G; Quaghebeur G; Price S; Prabhakar P; Marinova J; Brown G; McShane T
    Arch Dis Child; 2013 Dec; 98(12):1004-7. PubMed ID: 24047924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expanded clinical phenotype and untargeted metabolomics analysis in RARS2-related mitochondrial disorder: a case report.
    Walimbe AS; Machol K; Kralik SF; Mizerik EA; Gofin Y; Bekheirnia MR; Gijavanekar C; Elsea SH; Emrick LT; Scaglia F
    BMC Neurol; 2024 Mar; 24(1):87. PubMed ID: 38438854
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel RARS2 Variants: Updating the Diagnosis and Pathogenesis of Pontocerebellar Hypoplasia Type 6.
    Zhang Y; Yu Y; Zhao X; Xu Y; Chen L; Li N; Yao R; Wang J; Yu T
    Pediatr Neurol; 2022 Jun; 131():30-41. PubMed ID: 35468344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further delineation of pontocerebellar hypoplasia type 6 due to mutations in the gene encoding mitochondrial arginyl-tRNA synthetase, RARS2.
    Glamuzina E; Brown R; Hogarth K; Saunders D; Russell-Eggitt I; Pitt M; de Sousa C; Rahman S; Brown G; Grunewald S
    J Inherit Metab Dis; 2012 May; 35(3):459-67. PubMed ID: 22086604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical, neuroradiological and genetic findings in pontocerebellar hypoplasia.
    Namavar Y; Barth PG; Kasher PR; van Ruissen F; Brockmann K; Bernert G; Writzl K; Ventura K; Cheng EY; Ferriero DM; Basel-Vanagaite L; Eggens VR; Krägeloh-Mann I; De Meirleir L; King M; Graham JM; von Moers A; Knoers N; Sztriha L; Korinthenberg R; ; Dobyns WB; Baas F; Poll-The BT
    Brain; 2011 Jan; 134(Pt 1):143-56. PubMed ID: 20952379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [QARS1 gene related glutaminyl-tRNA synthetase deficiency syndrome: report of three cases and a review of literature].
    Shen YW; Weng ZF; He W; Chen YH; Wang QH; Zou LP; Liu LY; Shang-Guan HK
    Zhonghua Er Ke Za Zhi; 2020 Dec; 58(12):1006-1012. PubMed ID: 33256324
    [No Abstract]   [Full Text] [Related]  

  • 15. A term neonate with early myoclonic encephalopathy caused by
    Xu Y; Wu BB; Wang HJ; Zhou SZ; Cheng GQ; Zhou YF
    Transl Pediatr; 2020 Oct; 9(5):707-712. PubMed ID: 33209735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RARS2 mutations in a sibship with infantile spasms.
    Ngoh A; Bras J; Guerreiro R; Meyer E; McTague A; Dawson E; Mankad K; Gunny R; Clayton P; Mills PB; Thornton R; Lai M; Forsyth R; Kurian MA
    Epilepsia; 2016 May; 57(5):e97-e102. PubMed ID: 27061686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Infantile-onset myoclonic developmental and epileptic encephalopathy: A new RARS2 phenotype.
    de Valles-Ibáñez G; Hildebrand MS; Bahlo M; King C; Coleman M; Green TE; Goldsmith J; Davis S; Gill D; Mandelstam S; Scheffer IE; Sadleir LG
    Epilepsia Open; 2022 Mar; 7(1):170-180. PubMed ID: 34717047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. RARS2 Mutations: Is Pontocerebellar Hypoplasia Type 6 a Mitochondrial Encephalopathy?
    van Dijk T; van Ruissen F; Jaeger B; Rodenburg RJ; Tamminga S; van Maarle M; Baas F; Wolf NI; Poll-The BT
    JIMD Rep; 2017; 33():87-92. PubMed ID: 27683254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel mutation in the promoter of RARS2 causes pontocerebellar hypoplasia in two siblings.
    Li Z; Schonberg R; Guidugli L; Johnson AK; Arnovitz S; Yang S; Scafidi J; Summar ML; Vezina G; Das S; Chapman K; del Gaudio D
    J Hum Genet; 2015 Jul; 60(7):363-9. PubMed ID: 25809939
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A non-coding variant in the Kozak sequence of RARS2 strongly decreases protein levels and causes pontocerebellar hypoplasia.
    Nicolle R; Altin N; Siquier-Pernet K; Salignac S; Blanc P; Munnich A; Bole-Feysot C; Malan V; Caron B; Nitschké P; Desguerre I; Boddaert N; Rio M; Rausell A; Cantagrel V
    BMC Med Genomics; 2023 Jun; 16(1):143. PubMed ID: 37344844
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.